Walmart Inc.
Consumer Discretionary • CIK: 0000104169
Loading...
What Changed
DOJ controlled substance trial (November 2027): monitor for pre-trial settlement...·Top positives count (5 → 2): verify in next 10-K whether identified strengths...·Opioid litigation: no current loss estimate disclosed — watch for settlement...
Filing Intelligence
Executive Summary
Operating cash flow generation is robust, with free cash flow increasing due to operational performance and tax efficiencies, supporting significant capital expenditures in technology and supply...
Key Concerns
- ●Walmart demonstrates strong revenue growth across segments, driven by comparable sales increases and omnichannel engagement, though...
- ●Management expresses confidence in liquidity and ability to fund operations and investments, while acknowledging ongoing macroeconomic...
- ●Significant ongoing litigation, particularly opioid-related matters and Asda equal value claims, presents material uncertainty and...
Key Strengths
- ●Margin performance shows improvement driven by disciplined inventory management and higher-margin businesses, despite increased operating...
- ●Capital allocation priorities focus on automation and growth initiatives, with a continued commitment to returning capital to shareholders...
Cash Flow Health
Capital Allocation & Returns
Prioritizing reinvestment over distributions
Operational Efficiency & Returns
QUARTERLY TRENDS
Last 8 quarters + TTM
| Metric | TTM | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q3 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | $713.2B | $190.7B↑6.2% | $179.5B↑1.2% | $177.4B↑7.1% | $165.6B↓8.3% | $180.6B↑6.5% | $169.6B↑0.1% | $169.3B↑4.8% | $161.5B |
Operating Income | $29.8B | $8.7B↑30.0% | $6.7B↓8.1% | $7.3B↑2.1% | $7.1B↓9.2% | $7.9B↑17.2% | $6.7B↓15.5% | $7.9B↑16.1% | $6.8B |
Net Income | $21.9B | $4.2B↓31.0% | $6.1B↓12.6% | $7.0B↑56.6% | $4.5B↓14.6% | $5.3B↑14.8% | $4.6B↑1.7% | $4.5B↓11.8% | $5.1B |
Operating Cash Flow | $41.6B | $14.1B↑55.1% | $9.1B↓29.7% | $12.9B↑139.2% | $5.4B↓60.0% | $13.5B↑106.1% | $6.6B↓45.8% | $12.1B↑185.0% | $4.2B |
Free Cash Flow | $14.9B | $6.1B↑224.0% | $1.9B↓71.1% | $6.5B↑1433.6% | $425.0M↓93.4% | $6.4B↑1630.6% | $372.0M↓94.1% | $6.3B↑1570.0% | $-427.0M |
Total Equity | N/A |
Valuation Analysis
Business Quality & Moat
Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)
Returns on Capital
DuPont Analysis (ROIC = NOPAT Margin × Asset Turnover)
Earnings Quality
Cash Conversion
1.90x
OCF / Net Income ✓
FCF Consistency
–
Positive quarters
Competitive Moat Indicators
Pricing Power
Capital Efficiency
Working Capital
Growth Quality & Momentum
Growth Rates
Margin Quality & Sustainability
Quality = stability + cash conversion + low dilution